Evidence mapPaperPMID 41003951Full record

ReviewCurrent environmental health reports2025

Harnessing Geospatial Artificial Intelligence (GeoAI) for Environmental Epidemiology: A Narrative Review.

Hari S Iyer, Seigi Karasaki, Li Yi, Yulin Hswen, Peter James, Trang VoPham

Abstract readReview
In one paragraph

Review in Current environmental health reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. An Exploration of Machine Learning Methods in Human Biomonitoring.International journal of environmental research and public health · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hari S IyerSection of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute, 120 Albany St. Tower 2, Office 8009, New Brunswick, NJ, 08901, USA. hari.iyer@rutgers.edu.
Seigi KarasakiEpidemiology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Li YiDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Yulin HswenDepartment of Biostatistics and Epidemiology, University of California San Francisco, San Francisco, CA, USA.
Peter JamesDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Trang VoPhamEpidemiology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI HELMUT ZARBL · 1988 to 2026
$47.4M
Project 4: Social isolation as a driver of AD/ADRD incidence and disparitiesP01AG082653 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Jacqueline Marie Torres · 2024 to 2026
$23.6M
Built Environment Assessment through Computer visiON (BEACON): Applying Deep Learning to Street-Level and Satellite Images to Estimate Built Environment Effects on Cardiovascular HealthR01HL150119 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JAMES, PETER · 2020 to 2024
$3.9M
Contributing Factors and Consequences of Cancer Health DisparitiesT32CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI Christopher I Li, AMANDA IRENE PHIPPS · 2017 to 2026
$3.7M
Neighborhoods and health across the life course: Early life inequities in food insecurity, diet quality, and chemical exposuresUG3OD035533 · OD · HARVARD PILGRIM HEALTH CARE, INC. · PI HACKER, MICHELE RENEE, JAMES-TODD, TAMARRA M · 2023 to 2024
$2.9M
Air pollution and health disparities in liver disease and cancerK01DK125612 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VOPHAM, TRANG · 2020 to 2024
$746k
Exposure to Per- and Polyfluoroalkyl Substances and Prostate Cancer: Opportunities for Prevention and Early DetectionK01ES035734 · NIEHS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Hari S Iyer · 2024 to 2026
$555k
NCI NIH HHS T32 CA094880NHLBI NIH HHS R01 HL150119NIA NIH HHS P01 AG082653NIA NIH HHS P01AG082653NIDDK NIH HHS K01 DK125612NIEHS NIH HHS K01 ES035734NIEHS NIH HHS K01ES035734, P30ES005022NIEHS NIH HHS P30 ES005022NIH HHS UG3 OD035533NIH Office of the Director UG3OD035533
6 · The paper itself

Abstract

purpose of reviewGeospatial analysis is an essential tool for research on the role of environmental exposures and health, and critical for understanding impacts of environmental risk factors on diseases with long latency (e.g. cardiovascular disease, dementia, cancers) as well as upstream behaviors including sleep, physical activity, and cognition. There is emerging interest in leveraging machine learning and artificial intelligence (AI) for environmental epidemiology research. In this review, we provide an accessible overview of recent advances. RECENT

findingsThere have been two major recent shifts in geospatial data types and analytic methods. First, novel methods for statistical prediction, combining geospatial analysis with machine learning and artificial intelligence (GeoAI), allow for scalable geospatial exposure assessment within large population health databases (e.g. cohorts, administrative claims). Second, the widespread adoption of smartphones and wearables with global positioning systems and other sensors has allowed for passive data collection from people, and when combined with geographic information systems, enables exposure assessment at finer spatial scales and temporal resolution than ever before. Illustrative examples include refining models for predicting outdoor air pollution exposure, characterizing populations susceptible to water pollution, and use of deep learning to classify Street View image-derived measures of greenspace. While these tools and approaches may facilitate more rapid, higher quality objective exposure measures, they pose challenges with respect to participant privacy, representativeness of collected data, and curation of high quality validation sets for training of GeoAI algorithms. GeoAI approaches are beginning to be used for environmental exposure assessment and behavioral outcome ascertainment with higher spatial and temporal precision than before. Epidemiologists should continue to apply critical assessment of measurement accuracy and design validity when incorporating these new tools into their work.

Indexed as

Artificial IntelligenceEnvironmental ExposureEnvironmental HealthGeographic Information SystemsHumansArtificial intelligenceBig dataData scienceEnvironmental healthEpidemiologic methodsGeographic information systems

Identifiers

PMID41003951
PMCPMC12474636

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.